Baseline Clinical Characteristics

Slides:



Advertisements
Similar presentations
Sibbing D, et al. J Am Coll Cardiol 2009;53:
Advertisements

Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:
Effective Orifice Area Index Calculator
Ghanem et al., J Am Coll Cardiol 2010;55:1427–32..
ACC 2015 Michael J Reardon, MD, FACC On Behalf of the CoreValve US Investigators A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic.
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis George L. Zorn, III.
Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis David H. Adams et al (U.S. CoreValve Clinical Investigators) Journal Club November.
Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.
Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:
Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.
Heart valve disease in general practice: a clinical overview by Jessica Webb, Chris Arden, and John B Chambers BJGP Volume 65(632):e204-e206 March 2, 2015.
Clinical Trial Results. org RAAVE Luis M. Moura, MD; Sandra F. Ramos, MSc; José L. Zamorano, MD, PhD; Isabel M. Barros, MD; Luis F. Azevedo, MD; Francisco.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Accuracy of Statin Assignment Using the 2013 AHA/ACC.
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Uncertain Value of Renal Artery Interventions:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical efficacy of Doppler-echocardiographic indices.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Anticoagulation of Bioprosthetic Aortic Valves.
Nat. Rev. Cardiol. doi: /nrcardio
Terje R. Pedersen, M.D. Presented by Oslo, Norway
Trial profile SAS denotes the Simvastatin in Aortic Stenosis Study
Management strategy for patients with aortic stenosis
Baseline Characteristics of the Patients Part I
Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.
Oxford Niacin Trial.
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Nat. Rev. Cardiol. doi: /nrcardio
Figure 10 Assessment of myocardial fibrosis
Kuwabara et al. Am J Nephrol 2017;45:   (DOI: / )
Atorvastatin 20 mg (n=25 lesions) Atorvastatin 5 mg (n=25 lesions)
TECAM Trial design: STEMI patients who underwent successful reperfusion therapy were randomized on day 1 to intracoronary bone marrow autologous mononuclear.
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
Median total new lesion volume
Patrizio Lancellotti et al. JIMG 2016;9:
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 A patient with aortic and mitral stenosis
Figure 4 TAVI for bicuspid aortic valve disease
Terje R. Pedersen, M.D. Presented by Oslo, Norway
Figure 2 A patient with aortic stenosis and mitral regurgitation
End point Fenoldopam, n (%) Dopamine, n (%) p
Description of studies for pooled analyses
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.
Change in symptoms in operated and unoperated patients 1 year following evaluation of surgical AVR. Pie charts display change from baseline to follow-up.
Nat. Rev. Cardiol. doi: /nrcardio
Imran Niazi et al. JACEP 2017;j.jacep
Patient characteristics in the entire study group
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Clinical Characteristics and Atheroma Burden of Subjects at Baseline Stratified According to Gender Nicholls SJ. et al. J Am Coll Cardiol 2007;49:
Ioannis Smyrnias et al. JACC 2019;73:
Flow of Patients Through the Trial
Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.
Baseline Characteristics, Blood Pressures, and Laboratory Values
Baseline Characteristics of Study Subjects
Calcium on trial: Beyond a reasonable doubt?
Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.
Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)
Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.
Flow of study participants
Baseline characteristics of study population
Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:
Sung-Han Yoon et al. JACC 2017;69:
Patient selection process in the present study.
Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.
Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.
Presentation transcript:

Baseline Clinical Characteristics Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61

Flow chart of patient enrollment Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61

Changes in Hemodynamic Markers Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61

Annualized Changes in Hemodynamic Markers Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61

Changes in Serum Markers Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61

Progression of Aortic Valve Stenosis in Patients Treated With Rosuvastatin Therapy and Untreated Patients (B) Aortic mean gradient in treated versus untreated patients (C) Aortic valve area in treated versus untreated patients (A) Aortic jet velocity in treated versus untreated patients Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61

Correlation of LDL Cholesterol With Echocardiographic Hemodynamic Measurements in Treated Patients (B) Aortic mean gradient in treated patient (C) Aortic valve area in treated patients (A) Aortic jet velocity in treated patients Luis M. Moura, et al. J Am Coll Cardiol 2007;49:554–61